8-K//Current report
X4 Pharmaceuticals, Inc 8-K
Accession 0001501697-25-000032
$XFORCIK 0001501697operating
Filed
Oct 26, 8:00 PM ET
Accepted
Oct 24, 6:47 PM ET
Size
726.1 KB
Accession
0001501697-25-000032
Documents
- 8-Kxfor-20251023.htmPrimary
8-K
- EX-1.1ex11oct2025underwritingagr.htm
EX-1.1
- EX-4.1xforex41formofpre-fundedwa.htm
EX-4.1
- EX-5.1xfor-oct2025ex51opinion.htm
EX-5.1
- EX-101.SCHxfor-20251023.xsd
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
- EX-101.LABxfor-20251023_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
- EX-101.PRExfor-20251023_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
- GRAPHICimage_0a.jpg
- GRAPHICimage_1.jpg
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001501697-25-000032-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLxfor-20251023_htm.xml
IDEA: XBRL DOCUMENT
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001501697
Filing Metadata
- Form type
- 8-K
- Filed
- Oct 26, 8:00 PM ET
- Accepted
- Oct 24, 6:47 PM ET
- Size
- 726.1 KB